Posted by Michael Wonder on 04 Apr 2025
Uplinza (inebulizumab-cdon) is now the first and only FDA approved treatment for IgG4 related disease
3 April 2025 - Uplinza shown to deliver corticosteroid-free, flare-free, complete remission for patients in the MITIGATE trial.
Amgen announced today that the US FDA has approved Uplinza as the first and only treatment for adults living with Immunoglobulin G4-related disease.
